Foghorn Therapeutics
FHTX • NASDAQ
Foghorn Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Adrian H. Gottschalk, with a market cap of $281.2M.
Market Cap$281.2M
Employees116.0
CEOAdrian H. Gottschalk
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Foghorn Therapeutics FAQ
Common questions about Foghorn Therapeutics
Foghorn Therapeutics is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $8.4M.
Foghorn Therapeutics has approximately 116 employees.